(Q78442822)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

1 reference

Hiroyuki Konno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Megumi Baba

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Tuyoshi Shoji

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Manabu Ohta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Shohati Suzuki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Satoshi Nakamura

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

14 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

527-534

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405290%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1020392309715

14 December 2019

exact match

0 references

cites work

Expression of soluble urokinase plasminogen activator receptor may be related to outcome in prostate cancer patients.

1 reference

12 December 2020

Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44

1 reference

12 December 2020

A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells

1 reference

12 December 2020

Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator

1 reference

12 December 2020

Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells

1 reference

12 December 2020

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

1 reference

12 December 2020

Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer

1 reference

12 December 2020

Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model

1 reference

12 December 2020

Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression

1 reference

12 December 2020

Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

1 reference

12 December 2020

Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer

1 reference

12 December 2020

Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients

1 reference

12 December 2020

Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases

1 reference

12 December 2020

Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.

1 reference

12 December 2020

Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer.

1 reference

12 December 2020

The role of proteolytic enzymes in cancer invasion and metastasis

1 reference

12 December 2020

Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo

1 reference

12 December 2020

Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer

1 reference

12 December 2020

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours

1 reference

12 December 2020

Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas

1 reference

12 December 2020

Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines

1 reference

12 December 2020

Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.

1 reference

12 December 2020

Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.

1 reference

12 December 2020

Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size

1 reference

12 December 2020

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

1 reference

12 December 2020

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

1 reference

12 December 2020

Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines.

1 reference

12 December 2020

Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

1 reference

12 December 2020

Plasminogen activator inhibitors

1 reference

12 December 2020

Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder.

1 reference

12 December 2020

Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

1 reference

12 December 2020

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

12 December 2020

Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants

1 reference

12 December 2020

The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer

1 reference

12 December 2020

Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer

1 reference

12 December 2020

Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo

1 reference

12 December 2020

Activation of matrix metalloproteinase-2 in human breast cancer cells overexpressing cyclooxygenase-1 or -2.

1 reference

12 December 2020

Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells

1 reference

12 December 2020

Cyclooxygenase-2: a novel target for cancer chemotherapy?

1 reference

12 December 2020

Expression of cyclooxygenase-2 in human lung carcinoma

1 reference

12 December 2020

Plasminogen activator system in human breast cancer

1 reference

12 December 2020

Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues

1 reference

12 December 2020

Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma

1 reference

12 December 2020

Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3.

1 reference

12 December 2020

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.

1 reference

12 December 2020

Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac.

1 reference

12 December 2020

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

1 reference

12 December 2020